Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
Recruiting · NCT07100730 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma | Neoplasm Recurrence, Local, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 3 | 2026-08-11 | NCT07100730 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Telix Pharmaceuticals (Innovations) Pty Limited | 11 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Austin Health | Melbourne | Australia | 3 |
| Chu of Liège | Liège | Belgium | 1 |
| Gold Coast University Hospital | Gold Coast | Australia | 2 |
| Johannes Kepler University | Linz | Austria | 1 |
| Royal Adelaide Hospital | Adelaide | Australia | 18 |
| Sir Charles Gairdner Hospital | Perth | Australia | 3 |
| The Netherlands Cancer Institute (NKI) | Amsterdam | Netherlands | 2 |
| UMC Utrecht | Utrecht | Netherlands | 42 |
| UZ Leuven | Leuven | Belgium | 82 |